Z-2881-2026 Class III Ongoing

Recalled by Siemens Healthcare Diagnostics, Inc. — East Walpole, MA

FDA device recall Z-2881-2026 was initiated by Siemens Healthcare Diagnostics, Inc. on Jun 26, 2026 and is designated Class III. Reason for recall: out-of-specification sodium azide concentration in Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Lot U2. While the assay results were not impacted, the overall health risk to lab… The recall status is ongoing. Affected quantity: 494 US; 114 OUS.

Recall details

Product Type
Devices
Report Date
Aug 12, 2026
Initiation Date
Jun 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
494 US; 114 OUS

Product description

Syva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219UL

Reason for recall

out-of-specification sodium azide concentration in Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls Lot U2. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated.

Distribution pattern

Worldwide - US Nationwide distribution in the states CA, ID, IL, IN, MA, MS, NC, NM, NY, OH, OK, OR, PA, WA, and Northern Mariana Islands part of USA and the countries of Canada, South Africa, Brazil, Chile, Colombia.

Code information

UDI-DI 00842768014321 Lot U2

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2881-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2881-2026. Report a data issue: hello@regdatalab.com.